Burns Matteson Capital Management »

Ascendis Pharma A S shares owned by Burns Matteson Capital Management

Quarter-by-quarter ownership of Ascendis Pharma A S (ASND) shares owned by Burns Matteson Capital Management from 13F filings

Historical chart of Burns Matteson Capital Management investment in Ascendis Pharma A S

Tip: Access up to 7 years of quarterly data

All positions including Ascendis Pharma A S held by Burns Matteson Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ascendis Pharma A S by Burns Matteson Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $305k 1.4k 213.24
2025-09-30 $257k 1.3k 198.81

More positions owned by Burns Matteson Capital Management

Corning Stock (GLW)
Acco Brands Corp Stock Put Option
Invesco S&p 500 Quality Etf Etf (SPHQ)
Pacer Us Cash Cows 100 Etf Etf (COWZ)
State Street Spdr Portfolio Intermediate Term Corporate Bond Etf Etf (SPIB)
Ishares 5-10 Year Investment Grade Corporate Bond Etf Etf (IGIB)
Ishares Russell Top 200 Growth Etf Etf (IWY)
Schwab Us Dividend Equity Etf Etf (SCHD)
Invesco S&p Midcap Quality Etf Etf (XMHQ)
Spdr Gold Shares Etf (GLD)
Wisdomtree Dynamic International Equity Fund Etf (DDWM)
Ishares Russell Mid-cap Growth Etf Etf (IWP)
Wisdomtree Us Quality Dividend Growth Fund Etf (DGRW)
Schwab U.s. Large-cap Growth Etf Etf (SCHG)
Amazon Stock (AMZN)

View all positions for Burns Matteson Capital Management

Top funds holding Ascendis Pharma A S

RA Capital Management
Westfield Capital Management Company
venBio Select Advisor
FMR
Henderson Group
Artisan Partners Limited Partnership
Capital Research and Management Company - Division 3
Franklin Resources
Massachusetts Financial Services
Wellington Management Company
T. Rowe Price Investment Management
American Century Companies
Perceptive Advisors
Principal Financial Group
Susquehanna International

View all funds holding Ascendis Pharma A S